The FDA Issued a Recall on Thyroid Medication Nationwide
The FDA has issued a nationwide recall of levothyroxine sodium tablets due to the drug being described as subpotent.
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
- Velocity & Diffusion: Coverage escalated across 13 distinct news outlets with 13 published articles, achieving a live velocity of 12.
- Primary Driver: The FDA has issued a nationwide recall of levothyroxine sodium tablets due to the drug being described as subpotent.
- Predictive Outlook: Newsylist algorithmic models forecast this story will remain a dominant headline through tomorrow.
- Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.
The FDA has recalled levothyroxine sodium tablets across the United States. The recall affects multiple dosage strengths of the thyroid medication.
Coverage from NBC 7 San Diego, WTHR, News4JAX, WSB-TV, and EatingWell emphasizes that the medication has been identified as a subpotent drug. Reports highlight that the recall is nationwide in scope.
Further updates are expected regarding specific affected batches and guidance for patients using these medications.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 59d ago.
Coverage (13)
-
-
-
-
-
-
-
-
-
-
-
-
-
The FDA Issued a Recall on Thyroid Medication Nationwide EatingWell · 60d ago broke it first
Quick answers
What medication is being recalled?
Levothyroxine sodium tablets are being recalled.
Why was the recall issued?
The thyroid medication was described as a 'subpotent drug'.
What is the geographic scope of the recall?
The recall is nationwide, affecting dosage strengths across the U.S.
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.
People, places & organizations
Topics
Related trends
FDA Approves Alzheimer’s Blood Test Developed by Roche and Eli Lilly
The FDA has granted clearance to a new Alzheimer’s disease blood test developed by Roche and Eli Lilly.
US law to investigate foodborne illness outbreaks has been delayed for 15 years
A 15‑year freeze on a key food‑safety law is sparking congressional pressure as groups warn it hinders outbreak investigations.
Marketside soup sold at Walmart recalled over Listeria concerns: FDA
Marketside tomato bisque soup kits face a 29‑state recall over potential Listeria, hitting Walmart shoppers nationwide
Taylor Farms Voluntarily Recalls Fresh Jalapeños Over Salmonella Concerns
Taylor Farms recalls ready-to-eat foods and jalapeño products over salmonella concerns.
FDA approves 1st mRNA flu shot, from Moderna
The first mRNA-based influenza vaccine has received federal approval in the United States.
Nearly 12 million bottles of Rohto eye drops over sterility concerns, FDA announces
4 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.